![David Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Johnson
Président chez
AURA BIOSCIENCES, INC.
Fortune : 5 M $ au 30/06/2026
Profil
David M.
Johnson was the founder of VelosBio, Inc., founded in 2017, where the title held was Chief Executive Officer & Director from 2017 to 2020.
Mr. Johnson is the founder of Solve Therapeutics, Inc., founded in 2021, holding the title Chief Executive Officer & Director since 2021.
Current jobs include Non-Executive Chairman at Aura Biosciences, Inc. since 2021, Independent Director at Zentalis Pharmaceuticals, Inc. since 2024, Independent Director at Palleon Pharmaceuticals, Inc. since 2021, and Director at Sudo Biosciences, Inc. since 2021.
Former jobs include Chief Executive Officer at Acerta Pharma BV from 2013 to 2016, Chairman at Oncternal Oncology, Inc., Chairman at Lengo Therapeutics, Inc. in 2021, Director at AgFeed Industries, Inc. in 2011, and Director at Presage Biosciences, Inc. Education includes undergraduate studies at Indiana University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,47% | 11/06/2026 | 483 839 ( 0,47% ) | 3 M $ | 30/06/2026 |
| 16/06/2026 | 307 521 ( 0,43% ) | 1 M $ | 30/06/2026 |
Postes actifs de David Johnson
| Sociétés | Poste | Début |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/11/2024 |
| AURA BIOSCIENCES, INC. | Président | 01/01/2021 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Directeur/Membre du Conseil | 01/08/2021 |
Solve Therapeutics, Inc.
 Solve Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugates for treatment of cancer | Fondateur | 01/07/2021 |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de David Johnson
| Sociétés | Poste | Fin |
|---|---|---|
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Président | 01/12/2021 |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Fondateur | 01/12/2020 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Directeur Général | 01/03/2016 |
| AGFEED INDUSTRIES, INC. | Directeur/Membre du Conseil | 15/09/2011 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formation de David Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgFeed Industries, Inc.
 AgFeed Industries, Inc. Agricultural Commodities/MillingProcess Industries Manufactures and sells additive pre-mix and piglet blending feeds | Process Industries |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company and manufactures pharmaceutical products | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Solve Therapeutics, Inc.
Solve Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugates for treatment of cancer | Health Technology |
